{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:00:11Z","timestamp":1761519611240,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.clcc.2011.03.019","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T05:44:36Z","timestamp":1305870276000},"page":"198-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fatal Diffuse Alveolar Damage Associated with Oxaliplatin Administration"],"prefix":"10.1016","volume":"10","author":[{"given":"Jack","family":"Watkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian H.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annikka","family":"Weissferdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Overman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"Surveillance Epidemiology and End Results","key":"10.1016\/j.clcc.2011.03.019_bib1"},{"key":"10.1016\/j.clcc.2011.03.019_bib2","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andr\u00e9","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib3","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1200\/JCO.2006.08.2974","article-title":"Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07","volume":"25","author":"Kuebler","year":"2007","journal-title":"J Clin Oncol"},{"year":"2009","series-title":"ELOXATIN","key":"10.1016\/j.clcc.2011.03.019_bib4"},{"key":"10.1016\/j.clcc.2011.03.019_bib5","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1200\/JCO.2004.11.069","article-title":"XELOX (Capecitabine plus Oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer","volume":"22","author":"Cassidy","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10147-008-0863-2","article-title":"Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX)","volume":"14","author":"Muneoka","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12094-008-0285-7","article-title":"Fatal pneumonitis induced by oxaliplatin","volume":"10","author":"Ar\u00e9valo Lobera","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib8","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1378\/chest.07-0536","article-title":"Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report","volume":"132","author":"Garrido","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.clcc.2011.03.019_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02717006","article-title":"Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer","volume":"7","author":"Yag\u00fce","year":"2005","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00000421-200208000-00014","article-title":"Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer","volume":"25","author":"Gagnadoux","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib11","first-page":"1181","article-title":"Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)","volume":"10","author":"Jung","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.clcc.2011.03.019_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12094-009-0364-4","article-title":"Interstitial lung disease associated with oxaliplatin: description of two cases","volume":"11","author":"Pena \u00c1lvarez","year":"2009","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/09031936.01.18010243","article-title":"Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy","volume":"18","author":"Trisolini","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clcc.2011.03.019_bib14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12094-006-0072-2","article-title":"Pulmonary toxicity of 5-Fluoracil and oxaliplatin","volume":"8","author":"Ruiz-Casado","year":"2006","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib15","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.3748\/wjg.v12.i36.5907","article-title":"Is acute dyspnea related to oxaliplatin administration?","volume":"12","author":"Pasetto","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2011.03.019_bib16","first-page":"295","article-title":"Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)","volume":"36","author":"Ohori","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.clcc.2011.03.019_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bjc.6601155","article-title":"Hypersensitivity reactions related to oxaliplatin (OHP)","volume":"89","author":"Brandi","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2011.03.019_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.rmed.2007.09.001","article-title":"Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases","volume":"102","author":"Wilcox","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.clcc.2011.03.019_bib19","first-page":"177","article-title":"Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer","volume":"9","author":"Fekrazad","year":"2010","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2011.03.019_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00255453","article-title":"Lung damage from cytotoxic drugs","volume":"4","author":"Collis","year":"1980","journal-title":"Cancer Chemother Pharmacol"},{"issue":"suppl 2","key":"10.1016\/j.clcc.2011.03.019_bib21","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/sj.bjc.6602064","article-title":"Diagnosis and management of drug-associated interstitial lung disease","volume":"91","author":"Muller","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2011.03.019_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12016-007-8053-y","article-title":"Pulmonary eosinophilia","volume":"34","author":"Katz","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clcc.2011.03.019_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00000421-200202000-00021","article-title":"Gemcitabine-induced pulmonary toxicity: case report and review of the literature","volume":"25","author":"Gupta","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clcc.2011.03.019_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300281100020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300281100020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:56:12Z","timestamp":1761519372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153300281100020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S153300281100020X"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2011.03.019","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal Diffuse Alveolar Damage Associated with Oxaliplatin Administration","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2011.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}